Celgene Corp. has appointed CEO Mark Alles to the additional role of chairman, following the company's announcement that executive chairman Bob Hugin is to retire and step down from Celgene's board from Feb. 5, 2018. Hugin has spent 19 years at the Summit, NJ-headquartered company, initially joining in 1999 as chief financial officer, and then serving as president and COO from 2006 to 2010, and as CEO from 2010 to 2016.
The UK trade association, the Association of the British Pharmaceutical Industry (ABPI), has appointed Carole Longson as chief scientific officer....
